Autologous hematopoietic stem cell transplantation in chronic lymphocytic leukemia: results of European intergroup randomized trial comparing autografting versus observation.
暂无分享,去创建一个
R. Brand | M. Hallek | D. Catovsky | A. Gratwohl | D. Niederwieser | P. Dreger | C. Dearden | S. Richards | S. Choquet | M. Leporrier | T. D. de Witte | M. Sobh | D. Milligan | B. Corront | L. Sutton | M. Michallet | W. Herr | Marleen van Os
[1] A. Berrebi,et al. Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial , 2010, The Lancet.
[2] 高橋 徹,et al. 当科における造血器腫瘍患者に施行した Reduced Intensity Conditioning Stem Cell Transplantation の後方視的解析 , 2010 .
[3] N. Schmitz,et al. Early Autologous Stem Cell Transplantation (autoSCT) May Overcome the Adverse Impact of Del 11q- in Poor-Risk Chronic Lymphocytic Leukemia (CLL): Results From the GCLLSG CLL3 Trial. , 2009 .
[4] J. Delgado,et al. Allogeneic hematopoietic cell transplantation for chronic lymphocytic leukemia: ready for prime time? , 2009, Blood.
[5] K. Do,et al. Long-term results of the fludarabine, cyclophosphamide, and rituximab regimen as initial therapy of chronic lymphocytic leukemia. , 2008, Blood.
[6] N. Schmitz,et al. Quantitative MRD monitoring identifies distinct GVL response patterns after allogeneic stem cell transplantation for chronic lymphocytic leukemia: results from the GCLLSG CLL3X trial , 2008, Leukemia.
[7] P. Loehrer. Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial , 2008 .
[8] R. Brand,et al. Autologous stem cell transplantation for chronic lymphocytic leukemia. , 2007, Seminars in hematology.
[9] S. O'brien,et al. Chronic lymphocytic leukemia: diagnosis and treatment. , 2006, Mayo Clinic proceedings.
[10] E. Jantunen,et al. Autologous stem cell transplantation in patients with chronic lymphocytic leukaemia: the Finnish experience , 2006, Bone Marrow Transplantation.
[11] F. Ricci,et al. Alemtuzumab as consolidation after a response to fludarabine is effective in purging residual disease in patients with chronic lymphocytic leukemia. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] D. Catovsky,et al. High incidence of myelodysplasia and secondary leukaemia in the UK Medical Research Council Pilot of autografting in chronic lymphocytic leukaemia , 2006, British journal of haematology.
[13] E. Giné,et al. How I treat refractory CLL. , 2006, Blood.
[14] J. Gribben,et al. Autologous and allogeneic stem cell transplantations for poor-risk chronic lymphocytic leukemia. , 2005, Blood.
[15] R. Brand,et al. Reduced-intensity conditioning lowers treatment-related mortality of allogeneic stem cell transplantation for chronic lymphocytic leukemia: a population-matched analysis , 2005, Leukemia.
[16] A. López-Guillermo,et al. Allogeneic stem-cell transplantation may overcome the adverse prognosis of unmutated VH gene in patients with chronic lymphocytic leukemia. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] G. Morgan,et al. Results of the MRC pilot study show autografting for younger patients with chronic lymphocytic leukemia is safe and achieves a high percentage of molecular responses. , 2005, Blood.
[18] N. Schmitz,et al. The prognostic impact of autologous stem cell transplantation in patients with chronic lymphocytic leukemia: a risk-matched analysis based on the VH gene mutational status. , 2004, Blood.
[19] P. Feugier,et al. Impact of frontline fludarabine and cyclophosphamide combined treatment on peripheral blood stem cell mobilization in B-cell chronic lymphocytic leukemia. , 2004, Blood.
[20] S. Stilgenbauer,et al. Unmutated immunoglobulin variable heavy-chain gene status remains an adverse prognostic factor after autologous stem cell transplantation for chronic lymphocytic leukemia. , 2003, Blood.
[21] E. Montserrat,et al. Autologous and allogeneic stem cell transplantation for chronic lymphocytic leukemia , 2002, Leukemia.
[22] A. Rawstron,et al. Campath-1H and fludarabine in combination are highly active in refractory chronic lymphocytic leukemia. , 2002, Blood.
[23] J. Esteve,et al. Stem cell transplantation for chronic lymphocytic leukemia: different outcome after autologous and allogeneic transplantation and correlation with minimal residual disease status , 2001, Leukemia.
[24] R. Foà,et al. Clinical characteristics and outcome of young chronic lymphocytic leukemia patients: a single institution study of 204 cases. , 1999, Blood.
[25] G. Martinelli,et al. Fludarabine‐containing regimens severely impair peripheral blood stem cells mobilization and collection in acute myeloid leukaemia patients , 1999, British journal of haematology.
[26] C. D. Wu,et al. High incidence of relapse after autologous stem-cell transplantation for B-cell chronic lymphocytic leukemia or small lymphocytic lymphoma. , 1998, Annals of oncology : official journal of the European Society for Medical Oncology.
[27] N. Schmitz,et al. leukaemia: a chance for cure? , 2022 .
[28] J. Gribben,et al. Eradication of polymerase chain reaction-detectable chronic lymphocytic leukemia cells is associated with improved outcome after bone marrow transplantation. , 1996, Blood.
[29] M. Grever,et al. National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. , 1996, Blood.
[30] B. Andersson,et al. Autologous and allogeneic bone marrow transplantation for chronic lymphocytic leukemia: preliminary results. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[31] Mark J. Thomas,et al. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis , 1981, Cancer.
[32] L. Freedman,et al. Allocation of patients to treatment groups in a controlled clinical study. , 1978, British Journal of Cancer.
[33] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .